ORAMED PHARMACEUTICALS INC. ($ORMP)
Filing Information
| Accession Number | 0001213900-26-103538 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 25, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
420,746
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COO&CBO | Common Stock | โ | Sep 24, 2026 | Grant/Award | 75,455 | โ | โ | 1,148,839 | Direct | โ | View Details | |
COO&CBO | Common Stock | โ | Sep 24, 2026 | Grant/Award | 209,291 | โ | โ | 1,358,130 | Direct | โ | View Details | |
COO&CBO | Stock option (right to buy) | Derivative | Sep 24, 2026 | Sale to Issuer | 50,000 | โ | โ | 0 | Direct | โ | View Details | |
COO&CBO | Stock option (right to buy) | Derivative | Sep 24, 2026 | Sale to Issuer | 50,000 | โ | โ | 0 | Direct | โ | View Details | |
COO&CBO | Stock option (right to buy) | Derivative | Sep 24, 2026 | Sale to Issuer | 36,000 | โ | โ | 0 | Direct | โ | View Details |